Syndecan-4 promotes vascular beds formation in tissue engineered liver via thrombospondin 1

Abstract

Instantaneous blood coagulation after bioengineered liver transplantation is a major issue, and the key process in its prevention is the construction of the endothelial vascular bed on biomimetic scaffolds. However, the specific molecules involved in the regulation of the vascular bed formation remain unclear. Syndecan-4 is a type I transmembrane glycoprotein commonly expressed in the human body; its receptor has been reported as critical for optimal cell adhesion and initiation of intracellular signaling, indicating its promising application in vascular bed formation. In the current study, bioinformatics analysis and in vitro experiments were performed to evaluate whether syndecan-4 promoted endothelial cell migration and functional activation. Exogenous syndecan-4-overexpressing endothelial cells were perfused into the decellularized liver scaffold, which was assessed by Masson's trichrome staining. Western blotting and qRT-PCR were used to evaluate the effects of syndecan-4 on the thrombospondin 1 (THBS1) stability. We found that syndecan-4 promoted the adhesion of vascular endothelial cells and facilitated cell migration and angiogenesis. Furthermore, syndecan-4 overexpression resulted in a well-aligned endothelium on the decellularized liver scaffolds. Mechanistically, syndecan-4 destabilized THBS1 at the protein level. Therefore, our data revealed that syndecan-4 promoted the biological activity of endothelial cells on the bionic liver vascular bed through THBS1. These findings provide scientific evidences for solving transient blood coagulation after bionic liver transplantation.

Overexpressing long non-coding RNA OIP5-AS1 ameliorates sepsis-induced lung injury in a rat model via regulating the miR-128-3p/Sirtuin-1 pathway

“…After being sealed with 5% nonfat milk powder for an hour at regular atmospheric temperature, the membranes were flushed 3 times with TBST (10 min each) for the overnight incubation at 4°C along with the anti-SIRT1 antibody (1: 1000, Abcam, ab110304, MA, USA), anti-p-NF-κB antibody (phospho S536) (Abcam ab86299, 1: 1000), anti-NF-κB antibody (1: 1000, Abcam, ab32536, MA, USA), anti-iNOS antibody (1: 1000, Abcam, ab15323, MA, USA), anti-Bax antibody (1: 1000, Abcam, ab32503, MA, USA), anti-Bcl2 antibody (1: 1000, Abcam, ab182858, MA, USA), and anti-Caspase3 antibody (1: 1000, Abcam, ab13847, MA, USA). Following TBST washing, the membranes were incubated along with the anti-rabbit or anti-mouse secondary antibody (1: 3000) labeled by horseradish peroxidase (HRP) for 1 h [ 25 ]. TBST was applied to rinse the membranes three times (10 min each).…”

Angiotensin (ang) 1-7 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1))

“…The sections were stained with ponceau acid fuchsin staining buffer for 5 min, rinsed quickly with distilled water, treated with a phosphomolybdic acid aqueous solution for 3 min, re-stained by aniline blue solution 5 min, treated with 1% glacial acetic acid 1 min, dehydrated and transparent, dried and sealed. Microscopic examination was performed for image acquisition and analysis [ 22 , 23 ]. Collagen volume fraction was analyzed by Image J (National Institutes of Health, USA).…”

Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2

“…Western blotting assay was conducted according to previous study [ 24 ]. The total protein was collected and its level was determined using a BCA kit.…”